Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (101-110 of 200) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|February 5, 2009
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary interventionGabriele Busch, Birgit Steppich, Dirk Sibbing, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 TrialKatharina Mayer, Dario Bongiovanni, Vincent Karschin, et al.
European Cardiology|May 6, 2024
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysisDirk Sibbing, Michael J Blaha, Rajinder Chawla, et al.
American Heart Journal|March 25, 2014
Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) studyK Anette Fiedler, Robert A Byrne, Stefanie Schulz, et al.
Thrombosis and Haemostasis|September 15, 2010
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatmentIsabell Bernlochner, Steven Steinhubl, Siegmund Braun, et al.
Thrombosis and Haemostasis|September 21, 2018
Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney DiseaseLaurent Bonello, Marc Laine, Gilles Lemesle, et al.
Thrombosis and Haemostasis|March 18, 2014
Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy--ISAR-CAUTIONK Anette Fiedler, Julinda Mehilli, Sebastian Kufner, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2019
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysisDominick J Angiolillo, Giuseppe Patti, Kam Tim Chan, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
Biomed Research International|August 1, 2015
Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)Amadea M Martischnig, Julinda Mehilli, Janina Pollak, et al.
Pageof 20

Showing results (101-110 of 200) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|February 5, 2009
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary interventionGabriele Busch, Birgit Steppich, Dirk Sibbing, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 TrialKatharina Mayer, Dario Bongiovanni, Vincent Karschin, et al.
European Cardiology|May 6, 2024
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysisDirk Sibbing, Michael J Blaha, Rajinder Chawla, et al.
American Heart Journal|March 25, 2014
Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) studyK Anette Fiedler, Robert A Byrne, Stefanie Schulz, et al.
Thrombosis and Haemostasis|September 15, 2010
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatmentIsabell Bernlochner, Steven Steinhubl, Siegmund Braun, et al.
Thrombosis and Haemostasis|September 21, 2018
Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney DiseaseLaurent Bonello, Marc Laine, Gilles Lemesle, et al.
Thrombosis and Haemostasis|March 18, 2014
Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy--ISAR-CAUTIONK Anette Fiedler, Julinda Mehilli, Sebastian Kufner, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2019
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysisDominick J Angiolillo, Giuseppe Patti, Kam Tim Chan, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
Biomed Research International|August 1, 2015
Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)Amadea M Martischnig, Julinda Mehilli, Janina Pollak, et al.
Pageof 20